per person for prescribed drugs than any other country and nearly a third of Americans said in one survey last year that they have avoided taking medications due to costs.last year that allowing Medicare to negotiate lower drug prices would save the U.S. nearly $290 billion in new revenue and savings over a decade, the Pharmaceutical Research and Manufacturers of America on Wednesday became the latest pro-industry group to sue over the provision, arguing the law is unconstitutional.
"I expect the Biden administration to vigorously defend Medicare's bargaining power so seniors will see the lower drug prices they expect," said Wyden. "This legal action underscores how critical it is to have a president in the White House who will fight for lower health costs for Americans. I have deep concerns that a Republican administration would roll out the red carpet for Big Pharma and once again ban Medicare from negotiating lower drug prices.
PhRMA was joined by the National Infusion Center Association and the Global Colon Cancer Association in the legal challenge, which follows a lawsuit filed byBristol Myers Squibb have also sued over the provision this month, with the latter"We remain very concerned about the impact this law will have on patients and future innovation," PhRMA CEO Steve UblThe economic justice campaign Unrig Our Economy said Big Pharma is fighting any provision to help Medicare beneficiaries "while...
\u201cWish we were shocked but we're not \n\nWhile hard working families struggle to pay for life saving medicine, @PhRMA , @Merck\u00a0 and @bmsnews, and @USChamber are suing the government for letting Medicare negotiate for lower drug prices\n\nhttps://t.co/GN02FLksUK\u201d